UNGARO SCENTS TO STAY: Ferragamo Parfums intends to keep its Emanuel Ungaro license. Following a report in these columns Wednesday, the company has said it is in talks to sell its parent Emanuel Ungaro business. However, a spokeswoman for Ferragamo Parfums said Salvatore Ferragamo would hold onto the Ungaro fragrance license “regardless of whether Ungaro was sold or not.” Ferragamo Parfums helped found the Emanuel Ungaro fragrance license in 1997, alongside the designer and Bulgari Parfums. Last year, Ferragamo Parfums launched Apparition, the brand’s signature women’s scent, which helped contribute to a 50 percent jump in sales of its fragrance division, compared with the prior year.

Meanwhile, Ferragamo Parfums recently appointed Paolo Bevegni as its new export director to help continue consolidate and increase sales of the division. Bevegni’s previous positions include export director for Miceys Company, which produces Pupa cosmetics and fragrances, and with Versace Profumi.

MARIONNAUD INVESTIGATION: A French securities regulator said Thursday it is initiating proceedings against a number of people connected to Marionnaud Parfumeries. A spokeswoman for the Autorite des Marches Financiers said the “proceedings concern irregularities in Marionnaud’s financial disclosures for 2004, 2003 and 2002.” She would not specify who is being targeted by the proceedings. Marcel Frydman and his two sons, Gerald and Jean-Pierre, left the business in September, seven months after selling the troubled chain to A.S. Watson, a subsidiary of Hutchison Whampoa. The sanction procedure will take several months and will culminate in a hearing, during which the regulator could impose fines of up to 1.5 million euros, or $1.8 million at current exchange. Marionnaud is also under pressure from shareholders. APPAC, a small shareholders association, is undertaking criminal proceedings against the firm. Separately, an association of 120 shareholders is pursuing the retailer in commercial court, claiming it provided false financial information.

LIMITED BRANDS PROMOTION: Victoria’s Secret Beauty, a division of Limited Brands, has named Joyce Avalon senior vice president of specialty brands and focus stores, effective immediately. Avalon will report directly to Christine Beauchamp, president and general merchandise manager of Victoria’s Secret Beauty. She will be responsible for developing and marketing specialty brands to drive sales in more than 50 focus store locations. “Joyce is highly talented and creative; we are thrilled that she will move into this newly expanded role,” stated Beauchamp. Prior to her latest appointment, Avalon contributed as a consultant to advance the specialty brands development of Victoria’s Secret Beauty, identifying new brands and developing relationships to enhance the VSB portfolio. She has also worked in senior sales, marketing and merchandising roles at Nars, Fresh, Philosophy and Chanel, as well as at Barneys New York as vice president and divisional merchandise manager for cosmetics.

This story first appeared in the October 14, 2005 issue of WWD. Subscribe Today.

HOMEWARD BOUND: Lakewood, Ohio-based The Bonne Bell Co. closed its New York office on Oct. 4, citing a need to align its marketing and communication efforts. In an e-mail announcing the change, the company’s chief marketing officer, James Ward, stated, “We believe that marketing and franchise teams for the Bonne Bell and Smackers brands need to lead public relations and media activities to ensure a consistent synergistic message for their respective brands.” Brenda Lilly, director of media planning, will remain in her current role and will work remotely from her home in Westchester County in New York.

EXECUTIVE MOVE: Rite Aid has promoted Jim Mastrian to chief operating officer. In his new position, Mastrian, formerly senior executive vice president, marketing, logistics and pharmacy services, will have overall responsibility for all store operations, category management, marketing, merchandising, supply chain, pharmacy services and the company’s new pharmacy benefit management company.

load comments
blog comments powered by Disqus